Connection

Armand Glassman to Humans

This is a "connection" page, showing publications Armand Glassman has written about Humans.
Connection Strength

0.320
  1. Albert Cannon, MD (1/15/1921 - 9/20/2015). Ann Clin Lab Sci. 2016; 46(1):3-4.
    View in: PubMed
    Score: 0.021
  2. The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2005 Apr 01; 158(1):88-91.
    View in: PubMed
    Score: 0.010
  3. Determination of secondary chromosomal aberrations of chronic myelocytic leukemia. Cancer Genet Cytogenet. 2004 Aug; 153(1):53-6.
    View in: PubMed
    Score: 0.009
  4. Detection of a novel reciprocal t(16;22)(q11.2;q12) in a Ewing sarcoma. Cancer Genet Cytogenet. 2003 Jan 01; 140(1):55-7.
    View in: PubMed
    Score: 0.008
  5. Translocation (11;16)(q23;p13) acute myelogenous leukemia and myelodysplastic syndrome. Ann Clin Lab Sci. 2003; 33(3):285-8.
    View in: PubMed
    Score: 0.008
  6. Spectral karyotyping study of chromosome abnormalities in human leukemia. Cancer Genet Cytogenet. 2001 Jun; 127(2):143-7.
    View in: PubMed
    Score: 0.008
  7. A unique, complex variant philadelphia chromosome translocation in a patient with typical chronic myelogenous leukemia. Arch Pathol Lab Med. 2001 Mar; 125(3):437-9.
    View in: PubMed
    Score: 0.007
  8. Detection of trisomy 8 in philadelphia chromosome-positive CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques and its relation to c-myc involvement. Ann Clin Lab Sci. 2001 Jan; 31(1):68-74.
    View in: PubMed
    Score: 0.007
  9. Enhanced detection of chromosomal abnormalities with the use of RxFISH multicolor banding technique. Cancer Genet Cytogenet. 2000 Apr 15; 118(2):108-11.
    View in: PubMed
    Score: 0.007
  10. Chromosomal abnormalities in acute leukemias. Clin Lab Med. 2000 Mar; 20(1):39-48.
    View in: PubMed
    Score: 0.007
  11. Cytogenetics as an aid in the diagnosis of lymphomas. Ann Clin Lab Sci. 2000 Jan; 30(1):72-4.
    View in: PubMed
    Score: 0.007
  12. Cytogenetics, in situ hybridization and molecular approaches in the diagnosis of cancer. Ann Clin Lab Sci. 1998 Nov-Dec; 28(6):324-30.
    View in: PubMed
    Score: 0.006
  13. A simple efficient method of sequential G-banding and fluorescence in situ hybridization. Cancer Genet Cytogenet. 1998 May; 103(1):62-4.
    View in: PubMed
    Score: 0.006
  14. Chromosome 6 abnormalities associated with prolymphocytic acceleration in chronic lymphocytic leukemia. Ann Clin Lab Sci. 1998 Jan-Feb; 28(1):24-9.
    View in: PubMed
    Score: 0.006
  15. Interphase fluorescence in situ hybridization analysis: a study using centromeric probes 7, 8, and 12. Ann Clin Lab Sci. 1998 Jan-Feb; 28(1):51-6.
    View in: PubMed
    Score: 0.006
  16. Hemostatic abnormalities associated with cancer and its therapy. Ann Clin Lab Sci. 1997 Nov-Dec; 27(6):391-5.
    View in: PubMed
    Score: 0.006
  17. Cytogenetics. An evolving role in the diagnosis and treatment of cancer. Clin Lab Med. 1997 Mar; 17(1):21-37.
    View in: PubMed
    Score: 0.006
  18. The relationship between age and karyotypic abnormalities in myelodysplastic syndromes. Cancer Genet Cytogenet. 1996 May; 88(1):80-2.
    View in: PubMed
    Score: 0.005
  19. Breast cancer cytogenetics: a review and proposal for clinical application. Ann Clin Lab Sci. 1996 May-Jun; 26(3):208-14.
    View in: PubMed
    Score: 0.005
  20. Translocation (X;10)(p10;p10): A rare but nonrandom chromosomal abnormality in acute leukemia of myeloid differentiation. Cancer Genet Cytogenet. 1996 Feb; 86(2):153-5.
    View in: PubMed
    Score: 0.005
  21. Implications of human T-lymphotropic virus type-I and type-II testing in donors and patients. Ann Clin Lab Sci. 1995 Sep-Oct; 25(5):373-80.
    View in: PubMed
    Score: 0.005
  22. Cytogenetics, gene fusions, and cancer. Ann Clin Lab Sci. 1995 Sep-Oct; 25(5):389-93.
    View in: PubMed
    Score: 0.005
  23. der(1;15)(q10;10): a nonrandom chromosomal abnormality of myeloid neoplasia. Cancer Genet Cytogenet. 1995 Sep; 83(2):144-7.
    View in: PubMed
    Score: 0.005
  24. Neonatal alloimmune thrombocytopenia: current considerations. Ann Clin Lab Sci. 1994 Sep-Oct; 24(5):407-11.
    View in: PubMed
    Score: 0.005
  25. The Sox4/Tcf7l1 axis promotes progression of BCR-ABL-positive acute lymphoblastic leukemia. Haematologica. 2014 Oct; 99(10):1591-8.
    View in: PubMed
    Score: 0.005
  26. Thrombosis and coagulation abnormalities associated with cancer. Ann Clin Lab Sci. 1994 Jan-Feb; 24(1):1-5.
    View in: PubMed
    Score: 0.005
  27. Platelet abnormalities in diabetes mellitus. Ann Clin Lab Sci. 1993 Jan-Feb; 23(1):47-50.
    View in: PubMed
    Score: 0.004
  28. Human immunodeficiency virus type II (HIV-2) testing: a perspective. Ann Clin Lab Sci. 1992 Sep-Oct; 22(5):283-5.
    View in: PubMed
    Score: 0.004
  29. Ethics: a context for the clinical scientist. Ann Clin Lab Sci. 1991 May-Jun; 21(3):225-6.
    View in: PubMed
    Score: 0.004
  30. The lung permeability index: a feasible measurement of pulmonary capillary permeability. Respir Med. 2011 Feb; 105(2):230-5.
    View in: PubMed
    Score: 0.004
  31. Human immunodeficiency virus western blot tests: comparisons and considerations. Ann Clin Lab Sci. 1990 Sep-Oct; 20(5):343-6.
    View in: PubMed
    Score: 0.004
  32. Platelet abnormalities in hepatobiliary diseases. Ann Clin Lab Sci. 1990 Mar-Apr; 20(2):119-22.
    View in: PubMed
    Score: 0.003
  33. Hepatobiliary imaging: imaging modalities. Ann Clin Lab Sci. 1990 Jan-Feb; 20(1):56-9.
    View in: PubMed
    Score: 0.003
  34. Thrombocytopenia: proposed mechanisms and treatment in human immunodeficiency virus infection. Ann Clin Lab Sci. 1989 Sep-Oct; 19(5):319-22.
    View in: PubMed
    Score: 0.003
  35. Neutrophil antigens and antibodies in the diagnosis of immune neutropenias. Ann Clin Lab Sci. 1989 May-Jun; 19(3):146-54.
    View in: PubMed
    Score: 0.003
  36. Interleukin-2 and lymphokine activated killer cells: promises and cautions. Ann Clin Lab Sci. 1989 Jan-Feb; 19(1):51-5.
    View in: PubMed
    Score: 0.003
  37. Trichomonas vaginalis: preliminary characterization of a sperm motility inhibiting factor. Ann Clin Lab Sci. 1988 Nov-Dec; 18(6):484-9.
    View in: PubMed
    Score: 0.003
  38. Characterization of neutrophil agglutinins in primary autoimmune neutropenia of early childhood. Ann Clin Lab Sci. 1988 Sep-Oct; 18(5):367-73.
    View in: PubMed
    Score: 0.003
  39. Lymphomas: membrane markers and cell flow cytometric diagnosis. Ann Clin Lab Sci. 1987 Jan-Feb; 17(1):1-7.
    View in: PubMed
    Score: 0.003
  40. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases. Am J Clin Pathol. 2005 Nov; 124(5):807-14.
    View in: PubMed
    Score: 0.003
  41. Immunity during pregnancy: lymphocyte subpopulations and mitogen responsiveness. Ann Clin Lab Sci. 1985 Sep-Oct; 15(5):357-62.
    View in: PubMed
    Score: 0.003
  42. Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia. Am J Clin Pathol. 2005 Jun; 123(6):840-8.
    View in: PubMed
    Score: 0.002
  43. The utility of interphase fluorescence in situ hybridization for the detection of the translocation t(11;14)(q13;q32) in the diagnosis of mantle cell lymphoma on fine-needle aspiration specimens. Cancer. 2005 Apr 25; 105(2):110-8.
    View in: PubMed
    Score: 0.002
  44. Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha. Blood. 2005 Jun 15; 105(12):4573-5.
    View in: PubMed
    Score: 0.002
  45. Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia. Blood. 2005 Mar 15; 105(6):2281-6.
    View in: PubMed
    Score: 0.002
  46. Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: a preliminary study. Cancer. 2004 Oct 25; 102(5):322-7.
    View in: PubMed
    Score: 0.002
  47. Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations. Am J Clin Pathol. 2004 Sep; 122(3):348-58.
    View in: PubMed
    Score: 0.002
  48. t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia. Am J Clin Pathol. 2004 Jun; 121(6):836-42.
    View in: PubMed
    Score: 0.002
  49. Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome. Br J Haematol. 2004 Apr; 125(2):187-95.
    View in: PubMed
    Score: 0.002
  50. A genetically defined model for human ovarian cancer. Cancer Res. 2004 Mar 01; 64(5):1655-63.
    View in: PubMed
    Score: 0.002
  51. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis. Am J Clin Pathol. 2004 Mar; 121(3):402-7.
    View in: PubMed
    Score: 0.002
  52. Cytogenetic findings in blastoid mantle cell lymphoma. Hum Pathol. 2003 Oct; 34(10):1022-9.
    View in: PubMed
    Score: 0.002
  53. Bone marrow purging studies in acute myelogenous leukemia using the recombinant anti-CD33 immunotoxin HuM195/rGel. Biol Blood Marrow Transplant. 2003 Jun; 9(6):364-72.
    View in: PubMed
    Score: 0.002
  54. Quantitative measurement of BCR/abl transcripts using real-time polymerase chain reaction. Ann Oncol. 2002 May; 13(5):781-8.
    View in: PubMed
    Score: 0.002
  55. Myeloid disorders with deletion of 5q as the sole karyotypic abnormality: the clinical and pathologic spectrum. Leuk Lymphoma. 2002 Apr; 43(4):761-5.
    View in: PubMed
    Score: 0.002
  56. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood. 2002 Feb 01; 99(3):840-9.
    View in: PubMed
    Score: 0.002
  57. Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenstr?m macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course. Am J Clin Pathol. 2001 Oct; 116(4):543-9.
    View in: PubMed
    Score: 0.002
  58. Translocation t(17;18)(q10;q10): a new nonrandom chromosomal translocation of clonal evolution in chronic myeloid leukemia. Cancer. 2001 May 01; 91(9):1704-8.
    View in: PubMed
    Score: 0.002
  59. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma. Am J Clin Pathol. 2001 Apr; 115(4):571-81.
    View in: PubMed
    Score: 0.002
  60. Effects of insulin on phytohemagglutinin-P, concanavalin-A, and pokeweed mitogen in diabetic and nondiabetic lymphocytes. Ann Clin Lab Sci. 1981 Jan-Feb; 11(1):9-14.
    View in: PubMed
    Score: 0.002
  61. B and T lymphocytes: quantitation, function, and clinical applicability. Ann Clin Lab Sci. 1980 Nov-Dec; 10(6):455-62.
    View in: PubMed
    Score: 0.002
  62. 11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses. Am J Clin Pathol. 2000 Nov; 114(5):793-7.
    View in: PubMed
    Score: 0.002
  63. Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization. A useful ancillary method for the diagnosis of mantle cell lymphoma. Am J Clin Pathol. 2000 Aug; 114(2):248-57.
    View in: PubMed
    Score: 0.002
  64. Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia. J Clin Oncol. 2000 May; 18(9):1831-6.
    View in: PubMed
    Score: 0.002
  65. Numeric chromosomal abnormalities in small lymphocytic and transformed large cell lymphomas detected by fluorescence in situ hybridization of fine-needle aspiration biopsies. Cancer. 2000 Apr 25; 90(2):126-32.
    View in: PubMed
    Score: 0.002
  66. Acute myelomonocytic leukemia with histologic features resembling sarcomatoid carcinoma in bone marrow. Arch Pathol Lab Med. 2000 Feb; 124(2):315-8.
    View in: PubMed
    Score: 0.002
  67. Lymphocyte blast transformation and peripheral lymphocyte percentages in patients with sickle cell disease. Ann Clin Lab Sci. 1980 Jan-Feb; 10(1):9-12.
    View in: PubMed
    Score: 0.002
  68. Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implications. Leukemia. 1999 Jun; 13(6):869-72.
    View in: PubMed
    Score: 0.002
  69. T and B lymphocyte subpopulations in black patients with diabetes mellitus. Ann Clin Lab Sci. 1978 Nov-Dec; 8(6):467-71.
    View in: PubMed
    Score: 0.002
  70. Philadelphia chromosome-positive myeloid cells in the peripheral blood of chronic myelogenous leukemia patients: comparison with the frequency detected in cycling cells of the bone marrow. Clin Cancer Res. 1998 Apr; 4(4):861-7.
    View in: PubMed
    Score: 0.002
  71. Prognostic value of cytogenetics in multiple myeloma. Br J Haematol. 1998 Apr; 101(1):189-94.
    View in: PubMed
    Score: 0.002
  72. Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol. 1998 Mar; 16(3):1103-11.
    View in: PubMed
    Score: 0.002
  73. Applicability of direct in situ reverse transcription-polymerase chain reaction on bone marrow smears. Ann Clin Lab Sci. 1998 Jan-Feb; 28(1):34-42.
    View in: PubMed
    Score: 0.001
  74. Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis. 1997 Nov; 18(11):2063-9.
    View in: PubMed
    Score: 0.001
  75. B and T lymphocytes: methodology and normal ranges. Ann Clin Lab Sci. 1977 Nov-Dec; 7(6):519-23.
    View in: PubMed
    Score: 0.001
  76. Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro. Cancer Res. 1997 Apr 15; 57(8):1487-94.
    View in: PubMed
    Score: 0.001
  77. Downregulation of RAR alpha in mice by antisense transgene leads to a compensatory increase in RAR beta and RAR gamma and development of lymphoma. Blood. 1997 Apr 01; 89(7):2507-15.
    View in: PubMed
    Score: 0.001
  78. Expression profile of MDM-2 proteins in chronic lymphocytic leukemia and their clinical relevance. Am J Hematol. 1997 Mar; 54(3):189-95.
    View in: PubMed
    Score: 0.001
  79. Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia. Bone Marrow Transplant. 1997 Mar; 19(6):565-70.
    View in: PubMed
    Score: 0.001
  80. Underestimation of monoclonal proteins by agarose serum protein electrophoresis. Ann Clin Lab Sci. 1997 Mar-Apr; 27(2):123-9.
    View in: PubMed
    Score: 0.001
  81. Assessing the efficiency of leukoreduction of cellular blood components. Use of a simplified formalin-fixation and batch-counting method. Am J Clin Pathol. 1997 Jan; 107(1):111-3.
    View in: PubMed
    Score: 0.001
  82. Serum calcitonin in small cell carcinoma of the prostate. Ann Clin Lab Sci. 1996 Nov-Dec; 26(6):487-95.
    View in: PubMed
    Score: 0.001
  83. Comparison of bcr-abl protein expression and Philadelphia chromosome analyses in chronic myelogenous leukemia patients. Am J Clin Pathol. 1996 Oct; 106(4):442-8.
    View in: PubMed
    Score: 0.001
  84. The biologic function of PML and its role in acute promyelocytic leukemia. Leuk Lymphoma. 1996 Oct; 23(3-4):277-85.
    View in: PubMed
    Score: 0.001
  85. [Changes in the cell cycle in breast cancer]. Ginecol Obstet Mex. 1996 May; 64:230-5.
    View in: PubMed
    Score: 0.001
  86. Abnormal expression of MDM-2 in breast carcinomas. Breast Cancer Res Treat. 1996; 37(2):179-88.
    View in: PubMed
    Score: 0.001
  87. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes. Oncogene. 1995 Nov 16; 11(10):2121-6.
    View in: PubMed
    Score: 0.001
  88. p16INK4A and p15INK4B gene deletions in primary leukemias. Blood. 1995 Jul 01; 86(1):311-5.
    View in: PubMed
    Score: 0.001
  89. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology. 1993 Jul; 4(4):285-94.
    View in: PubMed
    Score: 0.001
  90. Serum insulin levels of "diabetic" and "nondiabetic" patients on chronic hemodialysis. Am J Clin Pathol. 1972 Mar; 57(3):320-3.
    View in: PubMed
    Score: 0.001
  91. Neutrophil agglutinins in idiopathic chronic neutropenia of early childhood. Am J Dis Child. 1986 Jan; 140(1):65-8.
    View in: PubMed
    Score: 0.001
  92. A computerized system for the identification of alloimmune neutropenia in neonates. Comput Methods Programs Biomed. 1985 Aug; 20(3):241-7.
    View in: PubMed
    Score: 0.001
  93. Incidence of neutrophil antigens on human cord neutrophils. Am J Reprod Immunol (1980). 1984 Oct-Nov; 6(3):124-7.
    View in: PubMed
    Score: 0.001
  94. Autoimmune neutropenia in early infancy: a review. Ann Clin Lab Sci. 1982 Sep-Oct; 12(5):356-67.
    View in: PubMed
    Score: 0.001
  95. Role of neutrophil antigen NA1 in an infant with autoimmune neutropenia. Am J Dis Child. 1982 Aug; 136(8):718-21.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.